FLN

Filana Therapeutics, Inc. Common Stock

FLNA • XNAS

Filana Therapeutics, Inc. Common Stock is a publicly traded company trading on XNAS, led by CEO Richard Jon Barry, with a market cap of $83.1M.

Market Cap$83.1M
Employees30.0
CEORichard Jon Barry
CountryUnited States of America
Next EarningsMay 7, 2026 · In 3 weeksQ1 2026

Financials

View all metrics
FLN

Filana Therapeutics, Inc. Common Stock FAQ

Common questions about Filana Therapeutics, Inc. Common Stock

Filana Therapeutics, Inc. Common Stock is scheduled to report earnings for Q1 2026 on May 7, 2026.

Filana Therapeutics, Inc. Common Stock has approximately 30 employees.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.

Filana Therapeutics, Inc. Common Stock (FLNA) Q1 2026 Earnings - OpenCapital